The need for a conceptual understanding of the macro and meso commercial determinants of health inequalities.

We take the opportunity here to expand on why we think this greater visibility is crucial and overdue. In particular, we want to describe how a particular focus on harmful product manufacturers, as a subsection within commercial actors, is worthy of inclusion as a meso-level influence. This is an area in which clear policy lever points, evidence and public opinion combine and have the potential for significant public health benefits.